The People's Ledger
← All Louisiana bills

HB870Introduced in the House

Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

Passed

Introduced by Christopher Turner, District 12

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)

Where it stands

Effective date: 08/01/2026.

June 12, 2026

How did lawmakers vote?

House votes

3 recorded votes · each counted separately

Senate votes

2 recorded votes · each counted separately

SenateStage: Senate Vote on HB 870 ADOPT (#1603) · May 31, 2026

36

Yes

0

No

3

Absent or Not Voting

39 senators recorded in this Senate vote. Colors show vote categories only, not whether a vote was good or bad.

See how each senator voted

SenatorDistrictVote
Robert Owen1Yes
Edward Price2Yes
Sidney Barthelemy3Yes
Jimmy Harris4Yes
Royce Duplessis5Yes
Rick Edmonds6Yes
Gary Carter7Yes
Patrick Connick8Yes
Cameron Henry9Yes
Kirk Talbot10Yes

Bill history

  1. Prefiled.

  2. Under the rules, provisionally referred to the Committee on Insurance.

  3. First appeared in the Interim Calendar on 2/27/2026.

  4. Read by title, under the rules, referred to the Committee on Insurance.

  5. Reported with amendments (10-0).

  6. Read by title, amended, ordered engrossed, passed to 3rd reading.

  7. Scheduled for floor debate on 04/09/2026.

  8. Read by title, returned to the calendar.

  9. Notice given.

  10. Scheduled for floor debate on 04/13/2026.

  11. Called from the calendar.

  12. Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.

  13. Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

  14. Read second time by title and referred to the Committee on Insurance.

  15. Reported with amendments.

  16. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.

  17. Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.

  18. Rules suspended.

  19. Read by title and returned to the Calendar, subject to call.

  20. Rules suspended. Called from the Calendar.

  21. Senate floor amendments read and adopted. Read by title, passed by a vote of 33 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.

  22. Received from the Senate with amendments.

  23. Scheduled for concurrence on 05/26/2026.

  24. Read by title, roll called, yeas 99, nays 0, Senate amendments rejected, conference committee appointment pending.

  25. Notice House rejected the Senate amendments.

  26. Senate conference committee members appointed: Talbot, Bass, and Harris.

  27. Notice of Senate conferees appointed.

  28. House conferees appointed: Turner, Firment, and Miller.

  29. Notice House Conference Committee members appointed.

  30. Conference Committee report received. Lies over under the rules.

  31. Conference committee report received.

  32. Scheduled for floor debate on 05/312026.

  33. Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted.

  34. Notice House adopted the Conference Committee Report.

  35. Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays.

  36. Notice of Senate adoption of Conference Committee Report.

  37. Enrolled and signed by the Speaker of the House.

  38. Signed by the President of the Senate.

  39. Sent to the Governor for executive approval.

  40. Signed by the Governor. Becomes Act No. 907.

  41. Effective date: 08/01/2026.

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.